ClinicalTrials.Veeva

Menu

Comparison of Physiological Effects of Two Types of High-Flow Oxygen Therapy in Tracheostomized Patients

J

Jian-Xin Zhou

Status

Not yet enrolling

Conditions

Critical Care
Oxygen Therapy
Tracheostomy

Treatments

Procedure: Standard high flow tracheal oxygen
Procedure: Modified high flow tracheal oxygen

Study type

Interventional

Funder types

Other

Identifiers

NCT06816745
IIT2024-158-002

Details and patient eligibility

About

High-flow nasal oxygen therapy offers benefits like precise oxygen delivery, flow-related positive end-expiratory pressure generation and improved lung function. High-flow oxygen therapy can be applied via tracheostomy as high-flow tracheal oxygen. While high-flow tracheal oxygen has been used to facilitate weaning, it has diminished physiological effects due to bypassing upper airways. To enhance its effectiveness, researchers developed a modified high-flow tracheal oxygen tube with a smaller expiratory end diameter to increase airway resistance and pressure. This is a prospective randomized crossover study that aims to compare the physiological effects of standard and modified high-flow oxygen therapy in tracheostomized patients.

Full description

High-flow nasal oxygen therapy has been shown to provide several physiological benefits, including precise control of the fraction of inspired oxygen, generation of flow-related positive end-expiratory pressure, increased end-expiratory lung volume, improved oxygenation, and enhanced carbon dioxide elimination. It has been widely utilized in managing acute hypoxemic respiratory failure and preventing hypoxemia after extubation.

High-flow oxygen therapy can be applied via tracheostomy as high-flow tracheal oxygen. Previous studies have reported successful cases of using high-flow tracheal oxygen to facilitate weaning from prolonged mechanical ventilation in patients with restrictive and obstructive pulmonary disorders. However, compared to high-flow nasal oxygen, high-flow tracheal oxygen exhibits significantly diminished physiological effects due to the bypassing of the narrow nasopharynx, glottis, and upper airway, as well as a more open circuit.

To address this limitation, the investigators have developed a modified high-flow tracheal oxygen tube with a reduced expiratory end tube diameter. This modification aims to create higher expiratory resistance and airway pressure, thus simulating the physiological effects of high-flow nasal cannula. This is a prospective randomized crossover physiological trial designed to compare the effects of standard and modified high-flow oxygen therapy in tracheostomized patients. Key physiological parameters will be assessed, including airway pressure, end-expiratory lung volume, vital signs, oxygenation, and respiratory workload.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Tracheostomy with stable spontaneous breathing.

Exclusion criteria

  1. Age younger than 18 years old
  2. Pregnancy
  3. Hemodynamic instability (mean arterial pressure <60 mmHg, heart rate >140 or <60 bpm)
  4. Respiratory and oxygenation instability (respiratory rate > 35bpm or oxygen saturation measured by pulse oximetry <90%)
  5. Neuromuscular diseases or phrenic nerve injury
  6. Recent trauma or surgery to the trachea, esophagus, neck, chest, or stomach
  7. Pneumothorax or placement of a chest drainage
  8. Contraindication to electrical impedance tomography (EIT) (implantable defibrillator)
  9. Anticipating withdrawal of life support

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

20 participants in 2 patient groups

Modified high flow tracheal oxygen
Experimental group
Description:
Modified high-flow tracheal oxygen with flow rates of 40L/ min and 60L/min will be performed in tracheostomized patients.
Treatment:
Procedure: Modified high flow tracheal oxygen
Standard high flow tracheal oxygen
Experimental group
Description:
Standard high-flow tracheal oxygen with flow rates of 40 L/min and 60 L/min will be performed in tracheostomized patients.
Treatment:
Procedure: Standard high flow tracheal oxygen

Trial contacts and locations

1

Loading...

Central trial contact

Jian-Xin Zhou, MD, PhD; Shan-Shan Xu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems